Annaly Capital Management, Inc. (NLY): Continuing the REIT Buying Spree

The mid-December announcement that American Realty Capital Properties Inc (NASDAQ:ARCP)  had issued an unsolicited takeover bid for its non-traded competitor Cole Credit Property Trust III stoked investor speculation that American had not yet completed its long-term REIT buying binge. Initially valued at more than $5.5 billion, the offer sought to create a mammoth property trust that specialized in renting to single-occupancy tenants.

For various reasons, Cole Credit determined that American’s initial offer undervalued its assets. As such, American returned with a higher offer that valued Cole at more than $6.5 billion. Barring unforeseen complications, this new deal appears likely to go through as planned. It should close by the end of the third quarter of 2013.

About American Realty Capital Properties Inc (NASDAQ:ARCP)

New York-based American Realty Capital Properties is a REIT that deals primarily with large-scale single-tenant commercial properties. In addition to its signature office space portfolio, the company also has significant retail holdings. Most of its properties are leased to recognizable firms with high credit ratings and stable business models. American Realty Capital Properties Inc (NASDAQ:ARCP) generally leases its properties on a medium-term basis. Once the company has combined with Cole, its portfolio will contain over 800 individual properties.

Annaly Capital (NYSE:NLY)

Competitors

Although it avoids investing directly in single-tenant commercial properties, Annaly Capital Management, Inc. (NYSE:NLY) Trust is often cited as one of American Realty Capital Properties’s biggest rivals. Annaly Capital Management, Inc. (NYSE:NLY) invests in a wide range of real estate-related financial instruments and credit vehicles, including mortgages, mortgage-backed securities and debt swaps. The company’s portfolio encompasses all geographical segments of the United States. In 2012, Annaly Capital Management, Inc. (NYSE:NLY) earned $1.7 billion on gross revenues of $2.1 billion.

While it is often compared to other raw materials firms, Weyerhaeuser Company (NYSE:WY) also functions as a de facto REIT. Of course, the company’s holdings largely take the form of undeveloped and in-development timberland. Altogether, the company leases or actively manages about 20 million acres of land in various parts of North America. In addition to its real estate investment operations, Weyerhaeuser Company (NYSE:WY) functions as a full-service timber harvesting and processing firm. It ships its products to home-improvement stores, contractors and other clients. In 2012, Weyerhaeuser earned $385 million on about $7.1 billion in gross revenues.

How the Deal Is Structured

Under the terms of the deal, American will issue cash payments of $12.50 per share to each holder of Cole’s non-traded stock. Alternatively, the company will offer .8 American share for each Cole share. Since Cole’s shares do not trade publicly, it is difficult to ascribe a relative valuation to this offer. However, the cash offer currently provides a significantly better deal than the stock offer. Relative to American’s current stock price, the stock offer values each Cole share at about $11.84. As such, those who accept the cash offer will earn a premium of about 5.6 percent.

However, this may be a moot point. American’s second offer explicitly states that it will pay no less than $13.59 per Cole share. This will be achieved through additional issues of fractional shares.

Although American’s proposal is worth about $6.7 billion, the total offer also includes the estimated $3 billion value of Cole’s outstanding property portfolio. As such, its true value is nearly $10 billion.

Complications and Legal Issues

Since American’s bid for Cole was not solicited, there is a possibility that Cole’s trustees could simply reject it out of hand. In the world of unsolicited takeover bids, this would be par for the course and might not come as a surprise to American’s management team.

However, there are reasons to believe that Cole is seriously considering the new offer and will ultimately acquiesce to the deal. Including Cole’s property portfolio, American has guaranteed combined cash and stock payments of at least $13.59 per non-traded Cole share.

Assuming that Cole’s management team and shareholders accept the deal, there appear to be no other legal or procedural hurdles to the timely completion of this takeover.

Long-Term Outlook and Possible Plays

Given the secular tailwinds that are finally beginning to appear in the commercial and residential property markets, all indications are that this deal will create significant value for the combined company’s shareholders. Indeed, the coming 12-month span may provide enterprising investors with a historic opportunity to invest in money-printing REITs during a period of healthy rents and steadily rising property values.

More broadly, this deal looks to continue American’s aggressive “add-on” growth strategy. By using cash and leverage to purchase smaller non-traded REITs, the company is clearly looking to grow more quickly than an organic growth strategy might allow. With this purchase, American promises to create one of the largest commercial REITs in existence and offer yields of more than 6 percent to its shareholders.

In sum, investors who wish to play this deal and others like it may wish to open long positions in American at these levels. Given the real estate market’s gathering strength, it seems likely that American will be able to raise its yield substantially in the coming quarters. Likewise, those who believe that American may target additional publicly traded REITs would do well to position themselves out in front of such deals.

The article Continuing the REIT Buying Spree originally appeared on Fool.com and is written by Mike Thiessen.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!